These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 8365036)

  • 41. Linear IgA disease and chronic active hepatitis--a coincidence or not?
    Oranje AP; Vuzevski VD; Bouquet J; Sinaasappel M; van Joost T; Stolz E
    Acta Derm Venereol; 1985; 65(5):440-2. PubMed ID: 2416172
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Reticulin and endomysial antibodies in bullous diseases. Comparison of specificity and sensitivity.
    Kumar V; Hemedinger E; Chorzelski TP; Beutner EH; Valeski JE; Kowalewski C
    Arch Dermatol; 1987 Sep; 123(9):1179-82. PubMed ID: 3307639
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Early diagnosis is key in vancomycin-induced linear IgA bullous dermatosis and Stevens-Johnson syndrome.
    Jones DH; Todd M; Craig TJ
    J Am Osteopath Assoc; 2004 Apr; 104(4):157-63. PubMed ID: 15127983
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Drug-induced linear IgA bullous dermatosis.
    Navi D; Michael DJ; Fazel N
    Dermatol Online J; 2006 Sep; 12(5):12. PubMed ID: 16962027
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Chronic bullous disease of childhood and linear IgA disease of adults are IgA1-mediated diseases.
    Wojnarowska F; Bhogal BS; Black MM
    Br J Dermatol; 1994 Aug; 131(2):201-4. PubMed ID: 7917982
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Chronic bullous dermatosis of childhood.
    Esterly NB; Furey NL; Kirschner BS; Kretschmer RR; Septon RM
    Arch Dermatol; 1977 Jan; 113(1):42-6. PubMed ID: 318816
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Linear IgA bullous dermatosis: the importance of a correct differential diagnosis].
    Colombo M; Volpini S; Orini S; Fazi MC; Vettore E; Tedoldi S; Cappellaro E
    Minerva Pediatr; 2008 Jun; 60(3):351-3. PubMed ID: 18487982
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Immunopathology of dermatitis herpetiformis and bullous pemphigoid (author's transl)].
    Bonerandi JJ; Dervaux-Baril D
    Ann Dermatol Venereol; 1980 Mar; 107(3):201-12. PubMed ID: 7020555
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Linear IgA dermatosis: a study of ten adult patients.
    Mobacken H; Kastrup W; Ljunghall K; Löfberg H; Nilsson LA; Svensson A; Tjernlund U
    Acta Derm Venereol; 1983; 63(2):123-8. PubMed ID: 6189326
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Polymorphic pemphigoid. Is it still worth using this terminology?
    Bernard P
    Dermatologica; 1989; 178(4):181-3. PubMed ID: 2670617
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Immunoglobulin, complement and epidermal transglutaminase deposition in the cutaneous vessels in dermatitis herpetiformis.
    Preisz K; Sárdy M; Horváth A; Kárpáti S
    J Eur Acad Dermatol Venereol; 2005 Jan; 19(1):74-9. PubMed ID: 15649195
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A morbilliform variant of vancomycin-induced linear IgA bullous dermatosis.
    Billet SE; Kortuem KR; Gibson LE; El-Azhary R
    Arch Dermatol; 2008 Jun; 144(6):774-8. PubMed ID: 18559768
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [IgA anti-endomysium antibodies in dermatitis herpetiformis: a sensitive marker of gluten enteropathy].
    Di Blasi A; Fuligni A; Geti V; Battini ML; Fabbri P
    G Ital Dermatol Venereol; 1990 May; 125(5):169-72. PubMed ID: 2253945
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The ultrastructural localization of IgA deposits in chronic bullous disease of childhood (CBDC).
    Dabrowski J; Chorzelski TP; Jablońska S; Kraińska T; Jarzabek-Chorzelska M
    J Invest Dermatol; 1979 Jun; 72(6):291-5. PubMed ID: 376753
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Childhood linear IgA bullous dermatosis in Tunisia.
    Kenani N; Mebazaa A; Denguezli M; Ghariani N; Sriha B; Belajouza C; Nouira R
    Pediatr Dermatol; 2009; 26(1):28-33. PubMed ID: 19250401
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pathophysiology of dermatitis herpetiformis: a model for cutaneous manifestations of gastrointestinal inflammation.
    Cardones AR; Hall RP
    Immunol Allergy Clin North Am; 2012 May; 32(2):263-74, vi. PubMed ID: 22560139
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Dermatitis herpetiformis sera or goat anti-transglutaminase-3 transferred to human skin-grafted mice mimics dermatitis herpetiformis immunopathology.
    Zone JJ; Schmidt LA; Taylor TB; Hull CM; Sotiriou MC; Jaskowski TD; Hill HR; Meyer LJ
    J Immunol; 2011 Apr; 186(7):4474-80. PubMed ID: 21335491
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A case of linear IgA bullous dermatosis with IgA anti-type VII collagen autoantibodies.
    Hashimoto T; Ishiko A; Shimizu H; Tanaka T; Dodd HJ; Bhogal BS; Black MM; Nishikawa T
    Br J Dermatol; 1996 Feb; 134(2):336-9. PubMed ID: 8746352
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Importance of image analysis in immunoelectron microscopy. Visualization of heterogeneous reactivity of sera from patients with linear IgA dermatitis bullosa with structures of the dermo-epidermal junction].
    Haftek M; Kowalewski C; Souchier C; Schmitt D
    Ann Pathol; 1995; 15(1):32-7. PubMed ID: 7702665
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Naproxen-associated linear IgA bullous dermatosis: case report and review.
    Bouldin MB; Clowers-Webb HE; Davis JL; McEvoy MT; Davis MD
    Mayo Clin Proc; 2000 Sep; 75(9):967-70. PubMed ID: 10994833
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.